Trial Offer to The Medical Letter
The Medical Letter on Drugs and Therapeutics is an indispensable tool that provides concise, critical, and authoritative drug information, giving you the expertise to make challenging treatment decisions.
SELECT
 Individuals - Sample Articles, Issues, and       CME
 Free Trial for institutions
Submit
All subscriptions include:
  • Unlimited online and mobile access - fully searchable
  • Up to 52 CME/MOC credits per year - accredited by ACCME, AAFP, AAPA, and ACPE
  • Critical appraisals of new drugs
  • Our "Drugs of Choice" articles that review all of the drugs for an indication, such as diabetes
  • Comparative tables for quick reference

The Medical Letter provides:
  • Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts
  • New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings
  • Consensus recommendations for the preferred and alternative treatments for common disorders
  • Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost
With over a quarter-million physician subscribers, as well as many of the leading academic and clinical institutions in the world, TML is a trusted source for drug information.
Because the Source Matters.
© 2021 The Medical Letter, Inc. All rights reserved. Use of this site signifies your agreement to the Terms and Conditions.